Synbiotic formula shows promise in reducing long COVID symptoms

Study finds that the synbiotic preparation SIM01 significantly reduces post-acute COVID-19 syndrome symptoms in patients, including fatigue, memory issues, and gastrointestinal distress, indicating its potential as a treatment for long COVID.

AI drug discovery company Genesis Therapeutics wins $200m in Series B round – Pharmaceutical Technology

The funds will go toward its Genesis Exploration of Molecular Space (GEMS) technology – a platform that uses generative and predictive AI technology to accelerate

August 21, 2023

Opinion | Out With the Old, In With the New

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director

December 31, 2024

Rising Share of New HIV Cases in Young Latinos Leads to Call for Targeted Funding

Four months after seeking asylum in the U.S., Fernando Hermida began coughing and feeling tired. He thought it was a cold. Then sores appeared in

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.